Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Core Scientific (CORZ) Equity Ratio: 2020-2025

Historic Equity Ratio for Core Scientific (CORZ) over the last 5 years, with Sep 2025 value amounting to -0.49.

  • Core Scientific's Equity Ratio rose 37.91% to -0.49 in Q3 2025 from the same period last year, while for Sep 2025 it was -0.49, marking a year-over-year increase of 37.91%. This contributed to the annual value of -0.51 for FY2024, which is 38.80% up from last year.
  • Latest data reveals that Core Scientific reported Equity Ratio of -0.49 as of Q3 2025, which was up 8.73% from -0.54 recorded in Q2 2025.
  • Over the past 5 years, Core Scientific's Equity Ratio peaked at 0.55 during Q4 2021, and registered a low of -1.44 during Q2 2024.
  • Its 3-year average for Equity Ratio is -0.61, with a median of -0.52 in 2023.
  • In the last 5 years, Core Scientific's Equity Ratio spiked by 641.70% in 2022 and then tumbled by 1,241.14% in 2023.
  • Core Scientific's Equity Ratio (Quarterly) stood at 0.55 in 2021, then tumbled by 192.16% to -0.51 in 2022, then tumbled by 65.39% to -0.84 in 2023, then surged by 38.80% to -0.51 in 2024, then surged by 37.91% to -0.49 in 2025.
  • Its Equity Ratio was -0.49 in Q3 2025, compared to -0.54 in Q2 2025 and -0.11 in Q1 2025.